图书简介

Foreword; Contributors; 1. Promise and Challenges in Drug Development and Assessment for Cognitive Enhancers; Jeffrey Cummings and Kate Zhong ; 2. The Neuroscience of Cognition and Cognitive Enhancing Compounds; Amy F.T. Arnsten, Min J. Wang, and Constantinos D. Paspalas; 3. Cognitive Enhancers for Alzheimer’s Disease; Po-Heng Tsai; 4. Cognitive Enhancement in Non-Alzheimer Dementias; Babak Tousi; 5. Cognitive Interventions in Parkinson’s Disease; Sarah Banks; 6. Cognitive Enhancement in Traumatic Brain Injury; Tessa Hart; 7. Cognitive Enhancement in Epilepsy; Beth A. Leeman-Markowsky and Kimford J. Meador; 8. Cognitive Enhancement at the Mild Cognitive Impairment Stage of Alzheimer’s Disease; Zara Melikyan, Heather Romero, and Kathleen A. Welsh-Bohmer; 9. Cognitive Enhancement in Schizophrenia; James Gilleen; 10. Cognitive Enhancement in Major Depressive Disorder; Andre F. Carvalho, Gilberto S. Alves, Cristiano A. Kohler, and Roger S. McIntyre; 11. Cognitive Enhancement in Bipolar Disorder; Katie Mahon, Manuela Russo, M. Mercedes Perez-Rodriguez; 12. Autism, ADHD, and Cognitive Enhancement; Iulia Dud, Louise Brennan, and Dene Robertson; 13. Targeted Treatment for Cognitive Impairment Associated with Cancer and Cancer Treatment; Shelli R. Kesler and Jeffrey S. Wefel; 14. Current Progress and Future Potential in the Evaluation and Treatment of Age-Related Cognitive Declines; Keith A. Wesnes and Helen J. Brooker; 15. Ethical Considerations in Cognitive Enhancement: Clinical Responsibilities and Duties; Jalayne J. Arias, Bryan Kibbe, and Paul J. Ford; 16. Regulatory Issues in Cognitive Enhancement; Nicholas Kozauer and Karl Broich

Trade Policy 买家须知